Finland· FI-REL-REL30643
Synflorix
A pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert product, registered in Finland by GlaxoSmithKline Biologicals SA. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AL52 (pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert · ATC J07AL52
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Fimea (Finland)- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- Finland (FI)
- ATC code
- J07AL52
- ATC class
- Pneumokokken, gereinigtes Polysaccharid-Antigen und Haemophilus influenzae B, konjugiert
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AL52
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert, as other registers publish it.
- DenmarkSynflorixGlaxoSmithKline Biologicals S.A.
- IcelandSynflorixGlaxoSmithKline Biologicals S.A.*
- BelgiumSynflorixGlaxoSmithKline Biologicals
- BelgiumSynflorixGlaxoSmithKline Biologicals
- FinlandSynflorixGlaxoSmithKline Biologicals SA
- BelgiumSynflorixGlaxoSmithKline Biologicals
- PolandSynflorixGlaxoSmithKline Biologicals S.A.
- BelgiumSynflorixGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6d5571bb-029a-46d8-963d-688aa380287e GET /v1/drugs/6d5571bb-029a-46d8-963d-688aa380287e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio, esitäytetty ruisku",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "pneumokokki ja Haemophilus influenzae -konjugaattirokote",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/09/508/001-005,010",
"fimea_rel_id": "REL30643",
"authorised_at": "2009-03-30"
}See everything about pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.